Department of Biomedical Engineering, T18-030, Health Sciences Center, State University of New York-Stony Brook, Stony Brook, NY 11794-8181, USA.
J Biomater Sci Polym Ed. 2010;21(3):329-42. doi: 10.1163/156856209X415864.
An in situ gelable glycation-resistant hydrogel has been prepared from oxidized alginate (Oalg) and gelatin. Aminoguanidine, an effective inhibitor of the glycation reaction, was first encapsulated in gelatin microspheres followed by incorporation into the hydrogel. The gelation process was monitored rheologically, and the results showed that the AMG-loaded Oalg/gelatin system solidified quickly at body temperature. Moreover, the hydrogels were highly porous, and the AMG-loaded microspheres dispersed in the hydrogels remained intact. Hydrogels' AMG loadings did not appear to change their degradation behaviors. AMG could be released from the hydrogels in a sustainable manner for a relatively short duration. Incorporation of AMG into the hydrogels resulted in imparting a glycation-resistant capability. Lastly, long-term in vitro incubation of all hydrogel formulations with fibroblasts did not reveal any cytotoxic potential.
一种可原位凝胶化的抗糖基化水凝胶已由氧化海藻酸钠(Oalg)和明胶制备而成。氨基胍是糖基化反应的有效抑制剂,首先将其包封在明胶微球中,然后再将其掺入水凝胶中。通过流变学监测凝胶化过程,结果表明,载 AMG 的 Oalg/明胶体系在体温下迅速凝固。此外,水凝胶具有高度多孔性,载 AMG 的微球在水凝胶中保持完整。载 AMG 的水凝胶的负载量似乎不会改变其降解行为。AMG 可以可持续地从水凝胶中释放出来,持续时间相对较短。将 AMG 掺入水凝胶中可以赋予其抗糖基化能力。最后,用成纤维细胞对所有水凝胶制剂进行长期体外孵育,并未显示出任何细胞毒性。